PACS PACS Group Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: PACS

Price (delayed)

$41.05

Market cap

$6.5B

P/E Ratio

24.01

Dividend/share

N/A

EPS

$1.71

Enterprise value

$9.59B

?
Relative Growth: Rel. Growth: 80
Relative Strength: Rel. Strength: 92
Relative Valuation: Rel. Valuation: 72
Relative Profitability: Rel. Profitability: 62

PACS is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. Founded in 2013, PACS is one of the largest post-acute platforms in the United States. Its ...

Highlights
PACS Group's net income has surged by 104% YoY and by 10% QoQ
PACS's EPS has soared by 99% YoY and by 10% QoQ
PACS's price to earnings (P/E) is 9% higher than its last 4 quarters average of 22.3
The quick ratio has declined by 8% since the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: https://pacs.com
Peers: HCA UHS EHC THC

Key stats

What are the main financial stats of PACS

PACS stock price

How has the PACS Group stock price performed over time
Intraday
-1.16%
1 week
-3.91%
1 month
-7.23%
1 year
217.72%
YTD
6.93%
QTD
-3.73%

Financial performance

How have PACS Group's revenue and profit performed over time
Revenue
$5.55B
Gross profit
$920.94M
Operating income
$410.32M
Net income
$269.17M
Gross margin
16.6%
Net margin
4.8%
PACS Group's net income has surged by 104% YoY and by 10% QoQ
PACS Group's operating income has soared by 84% YoY and by 8% from the previous quarter
The company's net margin has surged by 78% YoY and by 7% QoQ
The operating margin has soared by 61% YoY and by 6% from the previous quarter

Price vs fundamentals

How does PACS's price correlate with its fundamentals

Growth

What is PACS Group's growth rate over time

Valuation

What is PACS Group stock price valuation
P/E
24.01
P/B
5.85
P/S
1.17
EV/EBIT
23.25
EV/EBITDA
18.27
EV/Sales
1.73
PACS's EPS has soared by 99% YoY and by 10% QoQ
PACS's price to earnings (P/E) is 9% higher than its last 4 quarters average of 22.3
The equity has increased by 38% YoY and by 7% from the previous quarter
PACS's price to book (P/B) is 21% higher than its last 4 quarters average of 4.9
PACS's P/S is 31% above its last 4 quarters average of 0.9
The revenue has grown by 15% year-on-year and by 2.2% since the previous quarter

Efficiency

How efficient is PACS Group business performance
PACS Group's return on assets has surged by 92% YoY and by 9% QoQ
PACS Group's return on invested capital has surged by 59% YoY and by 6% QoQ
The ROE has soared by 50% YoY and by 2.3% from the previous quarter
PACS's ROS is up by 45% YoY and by 4.2% QoQ

Dividends

What is PACS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PACS.

Financial health

How did PACS Group financials performed over time
The total assets is 25% more than the total liabilities
The quick ratio has declined by 8% since the previous quarter
PACS Group's current ratio has decreased by 8% from the previous quarter
The company's debt is 193% higher than its equity
The equity has increased by 38% YoY and by 7% from the previous quarter
The debt to equity has contracted by 33% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.